WFC
58
8
PM
49
8
VFC
56
6
A
43
2
CTSH
55
3
TXN
29
4
BK
60
2
PVH
58
5
ROST
60
3
HRB
40
3
HES
49
2
HPE
48
2
MTCH
62
22
NWS
69
5
AAPL
64
3
EQT
47
13
PFE
37
4
TXT
46
4
VRSN
59
4
NKE
36
2
WFC
58
8
PM
49
8
VFC
56
6
A
43
2
CTSH
55
3
TXN
29
4
BK
60
2
PVH
58
5
ROST
60
3
HRB
40
3
HES
49
2
HPE
48
2
MTCH
62
22
NWS
69
5
AAPL
64
3
EQT
47
13
PFE
37
4
TXT
46
4
VRSN
59
4
NKE
36
2
Financhill
Back

Teladoc Health 10K Form

Sell
37

TDOC
Teladoc Health

Last Price:
$9.46
Seasonality Move:
6.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TDOC News And Ratings

See the #1 stock for the next 7 days that we like better than TDOC

TDOC Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $79M
Price / Cash Flow: 7.7
Annual Sales: $8.77
Price / Book: 1.08

Profitability

EPS (TTM): -5.77000
Net Income (TTM): $-981.7M
Gross Margin: $1.8B
Return on Equity: -49.49%
Return on Assets: -24.43%

Teladoc Health Earnings Forecast

Key Teladoc Health Financial Ratios

  • The Gross Profit Margin over the past 11 years for TDOC is 70.80%.
  • The Selling, General & Administrative Expenses for TDOC have been equal to 52.54% of Gross Profit Margin.
  • The Research & Development expenses have been 13.39% of Revenue.
  • The Interest Expense is -10.11% of Operating Income.
  • The Net Earning history of TDOC is -8.47% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Teladoc Health Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Technology
Sector: Health Care
Current Symbol: TDOC
CUSIP: 87918A
Website: teladochealth.com

Debt

Debt-to-Equity Ratio: 1.02
Current Ratio: 1.73
Quick Ratio: 1.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TDOC Technical Analysis vs Fundamental Analysis

Sell
37
Teladoc Health (TDOC) is a Sell

Is Teladoc Health a Buy or a Sell?

  • Teladoc Health stock is rated a Sell
    The current Teladoc Health [TDOC] share price is $9.44. The Score for TDOC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.